Newsy's Latest Health News

A study by CDC and Kaiser Health News reveals that Pfizer and Moderna vaccines are highly effective in preventing COVID-19 hospitalizations among seniors. Fully vaccinated individuals have the best protection, but even one dose significantly reduces hospitalization risk. However, seniors remain vulnerable in the first two weeks post-vaccination. Moderna plans to increase vaccine production to 3 billion doses in 2022, with facilities in the US, Switzerland, and Spain. The shelf life of Moderna's vaccine has also been extended to three months.

What is the new production target for Moderna's vaccine in 2022?

How has the shelf life of Moderna's vaccine changed according to the announcement?